Home >> Top News >> Quest to buy lab services business of Boyce and Bynum

Quest to buy lab services business of Boyce and Bynum

Print Friendly, PDF & Email

Dec. 13, 2018—Quest Diagnostics has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories; BBPL’s anatomic pathology division, long-term care division, and Boyce and Bynum Pathology Professional Services are not part of the transaction. Through a separate professional services agreement, BBPPS will become the exclusive pathology provider for Quest clients in Missouri and a preferred pathology provider in the greater Midwestern region.

“BBPL and Quest have complementary strengths that will improve access to superior diagnostic innovation by combining the anatomic pathology capabilities and clinical expertise of BBPPS and Quest,” Michael D. Curry, MD, PhD, medical director, president, and CEO of BBPL, said in a press release. “We are confident that Quest is the right organization to build on the progress and vision of BBPL to empower better health for patients in the Midwest.”

The professional services agreement will go into effect when the acquisition is completed, which is expected in the first quarter of 2019.


Check Also

Quest acquires two Texas labs, 7/17

July 2017—Quest Diagnostics has signed definitive agreements to acquire Med Fusion and Clear Point, both based in Lewisville, Tex., with the aim to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients nationwide. Baylor Scott & White Health; the US Oncology Network (the Network), supported by McKesson Specialty Health; Texas Oncology; and Pathologists Bio-Medical Laboratories are co-owners of one or both businesses.